Back to selection
Semester | fall semester 2025 |
Course frequency | Every fall sem. |
Lecturers |
Tobias Junt (tobias.junt@unibas.ch)
Stephan Krähenbühl (stephan.kraehenbuehl@unibas.ch) Alex Odermatt (alex.odermatt@unibas.ch) Gisbert Weckbecker (gisbert.weckbecker@unibas.ch, Assessor) |
Content | Disease-based molecular knowledge as prerequisite for identifying novel medications in preclinical and clinical settings (cf lecture content on ADAM, Special Topics DDD) Start-ups, big pharma and academic research as drivers of innovative drug-based therapies AI as potential game-changer in pharmaceutical sciences Natural compounds as starting points for efficacious therapies Peptidic drugs as highly potent endocrine modulators Digital platforms and novel analytical procedures enhancing the potential of biomarkers Antifungal approaches and their limiting adverse effects New developments e.g. in the treatment of Alzheimer's Role of drug agencies in drug development |
Learning objectives | Learn from current drug research activities in start-ups, big pharma and academic research |
Bibliography | For details and literature see ADAM |
Weblink | Department of Pharmaceutical Sciences |
Admission requirements | This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch |
Course application | This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch |
Language of instruction | English |
Use of digital media | No specific media used |
Interval | Weekday | Time | Room |
---|---|---|---|
wöchentlich | Monday | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Date | Time | Room |
---|---|---|
Monday 15.09.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 22.09.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 29.09.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 06.10.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 13.10.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 20.10.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 27.10.2025 | 10.15-12.00 | no lecture, exam week |
Monday 03.11.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 10.11.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 17.11.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 24.11.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 01.12.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 08.12.2025 | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Monday 15.12.2025 | 10.15-12.00 | no lecture, exam week |
Modules |
Doctorate Pharmaceutical Sciences: Recommendations (PhD subject: Pharmaceutical Sciences) Doctorate Toxicology: Recommendations (PhD subject: Toxicology) Electives Master Science in Pharmacy: Recommendations (Master's Studies: Pharmacy) Module Specialisation: Medical Nanosciences (Master's Studies: Nanosciences) Module: Clinical Drug Development: the Basis for Market Approval (Master's Studies: Drug Sciences) |
Assessment format | continuous assessment |
Assessment details | Compulsary 100% attendance and presentations by all students. More details will be communicated during the first lecture. |
Assessment registration/deregistration | Reg.: course registration, dereg: cancel course registration |
Repeat examination | no repeat examination |
Scale | Pass / Fail |
Repeated registration | as often as necessary |
Responsible faculty | Faculty of Science, studiendekanat-philnat@unibas.ch |
Offered by | Departement Pharmazeutische Wissenschaften |